Data Sources for Drug Utilization Research in Latin American countries – a cross‐national study: DASDUR‐LATAM Study

2021 ◽  
Author(s):  
Luciane C. Lopes ◽  
Maribel Salas ◽  
Claudia Garcia Serpa Osorio‐de‐Castro ◽  
Lisiane Freitas Leal ◽  
Svetlana V. Doubova ◽  
...  
Keyword(s):  
Drug Utilization ◽  
Latin American ◽  
Data Sources ◽  
National Study ◽  
Utilization Research ◽  
Drug Utilization Research ◽  
Cross National Study ◽  
Latin American Countries ◽  
Cross National

Variation in the Perceived Passage of Time: A Cross-National Study

2005 ◽  
Vol 68 (4) ◽  
pp. 400-410 ◽  
Author(s):  
Michael G. Flaherty ◽  
Betina Freidin ◽  
Ruth Sautu
Keyword(s):  
Latin American ◽  
Cultural Theory ◽  
Strong Support ◽  
Cross Cultural ◽  
National Study ◽  
Factors Associated ◽  
Experience Of Time ◽  
Cross National Study ◽  
American Nation ◽  
Cross National

Flaherty's cross-cultural theory purports to account for variation in the perceived passage of time. Recent events in Argentina provide an opportunity to assess the applicability of this theory to a Latin American nation. We conducted interviews with 198 persons who participated in various kinds of political activism. The respondents who felt that time had passed “quickly” emphasized an increase in governmental and personal activity. For those who said “slowly,” the focus was on suffering, unpleasant emotions, and waiting. Those who were unable to specify reported a mixture of factors associated with “quickly” or “slowly,” while those who said “synchronically” were unaffected by the turmoil in their country. These findings offer strong support for the theory in question, and they suggest that variation in the experience of time occurs not because there are different kinds of people but because people find themselves in different kinds of circumstances.

scholarly journals Data Sources for Drug Utilization Research in Brazil—DUR-BRA Study

2022 ◽  
Vol 12 ◽  
Author(s):  
Lisiane Freitas Leal ◽  
Claudia Garcia Serpa Osorio-de-Castro ◽  
Luiz Júpiter Carneiro de Souza ◽  
Felipe Ferre ◽  
Daniel Marques Mota ◽  
...  
Keyword(s):  
Adverse Event ◽  
Drug Utilization ◽  
Adverse Event Reporting ◽  
Data Sources ◽  
Event Reporting ◽  
Utilization Research ◽  
National Surveys ◽  
Reporting Systems ◽  
Data Source ◽  
Drug Utilization Research

Background: In Brazil, studies that map electronic healthcare databases in order to assess their suitability for use in pharmacoepidemiologic research are lacking. We aimed to identify, catalogue, and characterize Brazilian data sources for Drug Utilization Research (DUR).Methods: The present study is part of the project entitled, “Publicly Available Data Sources for Drug Utilization Research in Latin American (LatAm) Countries.” A network of Brazilian health experts was assembled to map secondary administrative data from healthcare organizations that might provide information related to medication use. A multi-phase approach including internet search of institutional government websites, traditional bibliographic databases, and experts’ input was used for mapping the data sources. The reviewers searched, screened and selected the data sources independently; disagreements were resolved by consensus. Data sources were grouped into the following categories: 1) automated databases; 2) Electronic Medical Records (EMR); 3) national surveys or datasets; 4) adverse event reporting systems; and 5) others. Each data source was characterized by accessibility, geographic granularity, setting, type of data (aggregate or individual-level), and years of coverage. We also searched for publications related to each data source.Results: A total of 62 data sources were identified and screened; 38 met the eligibility criteria for inclusion and were fully characterized. We grouped 23 (60%) as automated databases, four (11%) as adverse event reporting systems, four (11%) as EMRs, three (8%) as national surveys or datasets, and four (11%) as other types. Eighteen (47%) were classified as publicly and conveniently accessible online; providing information at national level. Most of them offered more than 5 years of comprehensive data coverage, and presented data at both the individual and aggregated levels. No information about population coverage was found. Drug coding is not uniform; each data source has its own coding system, depending on the purpose of the data. At least one scientific publication was found for each publicly available data source.Conclusions: There are several types of data sources for DUR in Brazil, but a uniform system for drug classification and data quality evaluation does not exist. The extent of population covered by year is unknown. Our comprehensive and structured inventory reveals a need for full characterization of these data sources.

scholarly journals Data transparency for building a stronger healthcare system: A case study from Argentinean administrative drug utilization data sources

2021 ◽  
Vol 17 ◽  
pp. e3339
Author(s):  
Martín Cañás ◽  
Gustavo H. Marín ◽  
Martín A. Urtasun ◽  
Lisiane Freitas Leal ◽  
Maribel Salas ◽  
...  
Keyword(s):  
Drug Utilization ◽  
Data Sources ◽  
Healthcare Sector ◽  
Bibliographic Databases ◽  
Public Healthcare ◽  
National Data ◽  
Cross Sectional ◽  
Utilization Research ◽  
Data Transparency ◽  
Drug Utilization Research

In order to compile an inventory of national data sources for drug utilization research (DUR) in Argentina and to verify publicly available data sources, we performed a cross-sectional study that sought to identify national and provincial databases of drug use. In July 2020, we searched the websites of government institutions, carried out a systematic query of bibliographic databases for “drug utilization research” conducted in Argentina, and conducted a survey with local experts. Data collected included: the institution responsible for the database, population covered, accessibility, source of the data, healthcare setting, geographic information, and whether data were individual or aggregated. Descriptive analyses were then performed. We identified 31 data sources for DUR; only one was publicly and conveniently accessible. Five published aggregated data and provide more detailed access by formal request. Only seven sources (23%) reported national data, and most (n=29) included only data from the public healthcare sector. Although data sources for DUR have been found in Argentina, limited access by researchers and policymakers is still an significant obstacle. Increasing health data transparency by making data sources publicly available for the purpose of analyzing public health information is crucial for building a stronger health system.

scholarly journals Challenges facing drug utilization research in the Latin American region

2020 ◽  
Vol 29 (11) ◽  
pp. 1353-1363 ◽  
Author(s):  
Maribel Salas ◽  
Luciane C. Lopes ◽  
Brian Godman ◽  
Ilse Truter ◽  
Abraham G. Hartzema ◽  
...  
Keyword(s):  
Drug Utilization ◽  
Latin American ◽  
Utilization Research ◽  
Latin American Region ◽  
Drug Utilization Research ◽  
American Region
Sign in / Sign up

Export Citation Format

Share Document